Mind Medicine (MindMed) Inc.
NASDAQ:MNMD
Overview | Financials
Company Name | Mind Medicine (MindMed) Inc. |
Symbol | MNMD |
Currency | USD |
Price | 7.08 |
Market Cap | 519,188,337 |
Dividend Yield | 0% |
52-week-range | 3.49 - 12.22 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Robert Barrow |
Website | https://www.mindmed.co |
An error occurred while fetching data.
About Mind Medicine (MindMed) Inc.
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD